Literature DB >> 10591936

Neurological complications of spinal tuberculosis in children.

A Y Mushkin1, K N Kovalenko.   

Abstract

Neurological complications of thoracic and lumbar spinal tuberculosis were studied in 32 patients under the age of 16 years. The majority had lesions involving three or more vertebral bodies. Paraplegia occurred in 8 patients and was always associated with bladder and bowel dysfunction. Lesions located at T4/5 were most commonly accompanied by paraplegia. Deterioration of the neurological status was related to the degree of spinal stenosis, whereas the degree of kyphosis was of less importance. Radiculopathy is rare in children with Pott's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591936      PMCID: PMC3619749          DOI: 10.1007/s002640050352

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  5 in total

1.  Posterior listhesis of a lumbar vertebra in spinal tuberculosis.

Authors:  Matthew Anthony Kirkman; Krishnamurthy Sridhar
Journal:  Eur Spine J       Date:  2010-08-06       Impact factor: 3.134

2.  Treatment of pediatric spinal tuberculosis abscess with percutaneous drainage and low-dose local antituberculous therapy: a preliminary report.

Authors:  Xin Hua Yin; Hong Qi Zhang; Xiong Ke Hu; Jin Song Li; Yong Chen; Ke Feng Zeng
Journal:  Childs Nerv Syst       Date:  2015-04-12       Impact factor: 1.475

3.  A Case of Cervical Spine Tuberculosis in an Infant.

Authors:  S N Singh; Trilok C Bhatt; Savit Kumar; Vikas Chauhan; Anjali Pandey
Journal:  J Clin Diagn Res       Date:  2016-01-01

4.  Pott's disease in children.

Authors:  Mohammed Benzagmout; Saïd Boujraf; Khalid Chakour; Mohammed El Faïz Chaoui
Journal:  Surg Neurol Int       Date:  2011-01-11

5.  A Prospective Study of Clinicoradiologic-Urodynamic Correlation in Patients with Tuberculosis of the Spine.

Authors:  Roop Singh; Milind Tanwar; Santosh Singh; Rajesh Kumar Rohilla
Journal:  Indian J Orthop       Date:  2019 Jul-Aug       Impact factor: 1.251

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.